Figure S1. Representative brightfield images for assay optimized cell densities from a DMSO-treated well on Day 10.</p
Movie S1. Showing the development of MitoSOX red fluorescence in DMSO-treated MCF-7 cells. (AVI 9250...
Figure S4. Assessment of cell viability upon treatment of MCF-7 (A) (B) monolayer cell...
<p><i>A,</i> SHRs were implanted with SST-2 cells and 24 h later were administered either doxorubici...
Figure S3. Heat maps of Bliss synergy scores across the combination dose-response matrices for all t...
Figure S2. Heat maps of Bliss synergy scores across the combination dose-response matrices for all t...
Figure S5. Heat maps of Bliss synergy scores across the combination dose-response matrices for all t...
Figure S4. Heat maps of Bliss synergy scores across the combination dose-response matrices for all t...
Figure S3. a SW837 cells were treated either with DMSO or the DOT1L inhibitor EPZ5676 (1 μM) for eit...
Additional file 1: Figure S1. Histological evaluation of HNSCC-derived tumor spheroids. Representati...
<p>The figure depicts EWS cellular response following DNA damage (DNA double-strand breaks and ROS p...
<p>HT29 cells were treated with the indicated compound for 24 hour and then fixed and stained with H...
Figure S1. The effect of VCR or Epirubicin on RMS cells in vitro. (A) RMS cell lines were treated wi...
Contains fulltext : mmubn000001_131440772.pdf (publisher's version ) (Open Access)...
Supplementary Figure S1 shows light microscopic images of CRC organoids and CAFs. Supplementary Figu...
<p>We reported, for each cell line, the means of log2(T/NT) data (Y-axis) gathered for each treatmen...
Movie S1. Showing the development of MitoSOX red fluorescence in DMSO-treated MCF-7 cells. (AVI 9250...
Figure S4. Assessment of cell viability upon treatment of MCF-7 (A) (B) monolayer cell...
<p><i>A,</i> SHRs were implanted with SST-2 cells and 24 h later were administered either doxorubici...
Figure S3. Heat maps of Bliss synergy scores across the combination dose-response matrices for all t...
Figure S2. Heat maps of Bliss synergy scores across the combination dose-response matrices for all t...
Figure S5. Heat maps of Bliss synergy scores across the combination dose-response matrices for all t...
Figure S4. Heat maps of Bliss synergy scores across the combination dose-response matrices for all t...
Figure S3. a SW837 cells were treated either with DMSO or the DOT1L inhibitor EPZ5676 (1 μM) for eit...
Additional file 1: Figure S1. Histological evaluation of HNSCC-derived tumor spheroids. Representati...
<p>The figure depicts EWS cellular response following DNA damage (DNA double-strand breaks and ROS p...
<p>HT29 cells were treated with the indicated compound for 24 hour and then fixed and stained with H...
Figure S1. The effect of VCR or Epirubicin on RMS cells in vitro. (A) RMS cell lines were treated wi...
Contains fulltext : mmubn000001_131440772.pdf (publisher's version ) (Open Access)...
Supplementary Figure S1 shows light microscopic images of CRC organoids and CAFs. Supplementary Figu...
<p>We reported, for each cell line, the means of log2(T/NT) data (Y-axis) gathered for each treatmen...
Movie S1. Showing the development of MitoSOX red fluorescence in DMSO-treated MCF-7 cells. (AVI 9250...
Figure S4. Assessment of cell viability upon treatment of MCF-7 (A) (B) monolayer cell...
<p><i>A,</i> SHRs were implanted with SST-2 cells and 24 h later were administered either doxorubici...
DOI
Add to ORKG